Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.

Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, Makita N, Kowase S, Boonmee N, Vitayakritsirikul V, Ratanarapee S, Sharma S, van der Wal AC, Christiansen M, Tan HL, Wilde AA, Nogami A, Sheppard MN, Veerakul G, Behr ER. · 2015

Read Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome. by Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, Makita N, Kowase S, Boonmee N, Vitayakritsirikul V, Ratanarapee S, Sharma S, van der Wal AC, Christiansen M, Tan HL, Wilde AA, Nogami A, Sheppard MN, Veerakul G, Behr ER. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4631798.txt.

Introduction

In 2015, Koonlawee Nademanee and colleagues published a study on the heart tissue behind Brugada syndrome, an inherited condition that can cause sudden death. The right ventricular outflow tract is blamed for the dangerous rhythms, but the tissue fault was disputed. The team examined six hearts from young men who died suddenly with family history of the syndrome. The work appeared in the Journal of the American College of Cardiology.

Case hearts held more scar-like collagen than matched control hearts, most of all in the outflow tract and its outer layer. A gap-junction protein, connexin-43, was reduced there too. In living patients, the same regions produced slow, fragmented electrical signals, and burning those spots erased the syndrome's signature tracing for about two years. Scarring plus weak cell connections explains the faulty conduction.

Catalog record

CREATORNademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, Makita N, Kowase S, Boonmee N, Vitayakritsirikul V, Ratanarapee S, Sharma S, van der Wal AC, Christiansen M, Tan HL, Wilde AA, Nogami A, Sheppard MN, Veerakul G, Behr ER.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4631798

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome By Koonlawee Nademanee, Hariharan Raju, Sofia V de Noronha, Michael Papadakis, Laurence Robinson, Stephen Rothery, Naomasa Makita, Shinya Kowase, Nakorn Boonmee, Vorapot Vitayakritsirikul, Samrerng Ratanarapee, Sanjay Sharma Published in: Journal of the American College of Cardiology DOI: 10.1016/j.jacc.2015.08.862 ABSTRACT Abstract Background The right ventricular outflow tract (RVOT) is acknowledged to be responsible for arrhythmogenesis in Brugada syndrome (BrS), but the pathophysiology remains controversial. Objectives This study assessed the substrate underlying BrS at post-mortem and in vivo, and the role for open thoracotomy ablation. Methods Six whole hearts from male post-mortem cases of unexplained sudden death (mean age 23.2 years) with negative specialist cardiac autopsy and familial BrS were used and matched to 6 homograft control hearts by sex and age (within 3 years) by random risk set sampling. Cardiac autopsy sections from cases and control hearts were stained with picrosirius red for collagen. The RVOT was evaluated in detail, including immunofluorescent stain for connexin-43 (Cx43). Collagen and Cx43 were quantified digitally and compared. An in vivo study was undertaken on 6 consecutive BrS patients (mean age 39.8 years, all men) during epicardial RVOT ablation for arrhythmia via thoracotomy. Abnormal late and fractionated potentials indicative of slowed conduction were identified, and biopsies were taken before ablation. Results Collagen was increased in BrS autopsy cases compared with control hearts (odds ratio [OR]: 1.42; p = 0.026). Fibrosis was greatest in the RVOT (OR: 1.98; p = 0.003) and the epicardium (OR: 2.00; p = 0.001). The Cx43 signal was reduced in BrS RVOT (OR: 0.59; p = 0.001). Autopsy and in vivo RVOT samples identified epicardial and interstitial fibrosis. This was collocated with abnormal potentials in vivo that, when ablated, abolished the type 1 Brugada electrocardiogram without ventricular arrhythmia over 24.6 ± 9.7 months. Conclusions BrS is associated with epicardial surface and interstitial fibrosis and reduced gap junction expression in the RVOT. This collocates to abnormal potentials, and their ablation abolishes the BrS phenotype and life-threatening arrhythmias. BrS is also associated with increased collagen throughout the heart. Abnormal myocardial structure and conduction are therefore responsible for BrS. Key Words: gap junction, myocardial fibrosis, right ventricular outflow tract, sudden arrhythmic death syndrome, sudden unexpected death Abbreviations and Acronyms: BrS, Brugada syndrome; Cx43, connexin-43; ECG, electrocardiogram; ICD, implantable cardioverter-defibrillator; LV, left ventricle/ventricular; OR, odds ratio; PSR, picrosirius red stain; RV, right ventricular; RVOT, right ventricular outflow tract; SADS, sudden arrhythmic death syndrome; SCD, sudden cardiac death; SCN5A, sodium channel, voltage gated, type V alpha subunit; VT, ventricular tachycardia; VF, ventricular fibrillation Brugada syndrome (BrS) is an inherited arrhythmia syndrome diagnosed by the presence of the type 1 Brugada electrocardiogram (ECG) (1). It was initially described in survivors of cardiac arrest without structural disease (2), and it is partly responsible for sudden arrhythmic death syndrome (SADS) 1, 3, 4. Potential causal variants in the cardiac sodium channel gene SCN5A are identified in 20% of cases (5). It was initially proposed that the basis for BrS was an abnormal transmural repolarization in the right ventricular outflow tract (RVOT) due to heterogeneous loss of the cardiomyocyte action potential dome in the epicardium (6). However, electrophysiological, imaging, and histopathological studies have identified subtle structural abnormalities in patients with BrS 7, 8, 9. Myocardial fibrosis has been suggested by abnormal, low-voltage, fractionated electrograms localized to the RVOT at the epicardium 9, 10. Ablation at these sites has eliminated the type 1 Brugada ECG pattern and successfully reduced arrhythmic events (10), as was seen in a previous experimental model (11). A study of sudden cardiac death (SCD) cases associated the type 1 ECG with arrhythmogenic right ventricular cardiomyopathy (8). Furthermore, SCD cases with a familial diagnosis of BrS showed structural abnormalities that were insufficient to fulfill the diagnostic criteria for cardiomyopathy or myocarditis (12). Other myocardial anomalies have been reported in selected cases 13, 14. Therefore, there is significant debate about the underlying substrate in BrS (15). To resolve this controversy, we tested the hypothesis that BrS is associated with fibrosis in the RVOT and altered expression of the gap junction protein connexin-43 (Cx43), which may be critical for correct cellular migration and maintenance of RVOT zonation 16, 17. We expected this to manifest as abnormal late and fractionated potentials at the RVOT epicardium. METHODS Study setting and cohorts Post-mortem BrS cohort From 2005 to 2010, 1,304 unexpected SCD cases were referred for specialist cardiac autopsy. We studied 6 male cases (B1 to B6; mean age 23.2 years) (Table 1), which fulfilled the following criteria for SADS (1): 1) age 1 to 64 years; 2) unexpected sudden death; 3) whole heart available; 4) heart morphologically normal at coronial/medical examiner and specialist cardiac autopsies; 5) no antemortem cardiac conditions; and 6) negative toxicological analysis. In addition, 1 or more first-degree blood relatives had to be diagnosed with BrS (Online Methods) following familial evaluation 1, 18, 19. [Table: Demographic Data, Familial Evaluation Results, and Index Presentation for the Included Post-Mortem BrS, Post-Mortem Control, and In Vivo BrS Cases] All 6 cases were asymptomatic before death, according to primary care records and family interview, with no family history of premature death. Five died at rest (4 during sleep) and 1 during exertion. None had undergone previous cardiac investigation. Post-mortem control cohort Six control cases (C1 to C6) (Table 1) of premature noncardiac death were identified from 407 consecutive homograft valve donors from Harefield Hospital, London (2010 to 2012). These were matched to the post-mortem BrS cases by random risk set sampling selection for age (within 3 years) and sex in a 1:1 ratio. Inclusion criteria for control cases were: 1) age 1 to 64 years; 2) absence of antemortem cardiac symptoms (syncope or seizures); 3) normal specialist cardiac autopsy; and 4) intact RVOT. In vivo BrS ablation cohort Six symptomatic male BrS patients (mean age 39.8 years) (Table 1) undergoing mapping and RVOT ablation during open thoracotomy were studied at Bhumibol Adulyadej Air Force Hospital (cases V1 to V5, Bangkok) and Yokohama Rosai Hospital (case V6, Japan). All had an implantable cardioverter defibrillator (ICD) before recruitment, with a clinical diagnosis (Online Methods) of BrS 1, 19, and normal echocardiography, computed tomography/magnetic resonance imaging, and coronary angiography. Thoracotomy was indicated for ICD lead extraction (V1, V2, V5, and V6) or to permit epicardial access for ablation after a failed percutaneous attempt (V3 and V4). Mutation analysis In vivo BrS subjects and clinically affected blood relatives of post-mortem cases were counseled and offered SCN5A mutation analysis. Mutation analysis was not undertaken in the autopsy cases due to lack of suitable unfixed material. Specialist cardiac post-mortem examination A systematic specialist post-mortem of the whole heart was undertaken, with macroscopic and microscopic evaluation in all referred SCD cases and control hearts, blinded to the results of familial evaluation (20). At least 20 tissue sections were sampled from each case, including the following: coronary arteries; ascending aorta; 4 sequential sections from the atrioventricular node to the branches of the His-Purkinje system; 4 sinoatrial node sections; and 2 RVOT sections. Sectioning of the anterior, lateral, and posterior left ventricle (LV), anterior and posterior interventricular septum, and right ventricle (RV) was performed at the midventricular level. Histological examination (Online Methods) was

Read the complete text